Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Asociación Argentina de Medicina Respiratoria: 12,000 pulmonary fibrosis cases

October 1, 2026 Dr. Michael Lee – Health Editor Health

Between 6,000 and 12,000 people live with idiopathic pulmonary fibrosis in Argentina, according to calculations released by the Asociación Argentina de Medicina Respiratoria on September 30, 2026. This disease scars lung tissue permanently over time, reducing the organ’s ability to transfer oxygen into the bloodstream. Clinicians warn that patients often face a diagnostic delay of one to two years because initial signs mimic more common respiratory ailments.

  • Diagnostic evaluations for pulmonary fibrosis frequently face delays of one to two years due to symptom overlap with asthma, bronchitis, and pneumonia.
  • Clinical suspicion is often raised during physical examinations by distinctive velcro-like crackling lung sounds heard through a stethoscope.
  • High-resolution computed tomography serves as the primary diagnostic imaging tool to identify structural alterations in the pulmonary interstitium.

Diagnostic Delays and Symptom Overlap in Clinical Practice

Persistent dry coughs and progressive breathlessness during routine physical activities like climbing stairs are frequently dismissed as normal signs of aging, sedentary lifestyles, or smoking habits. Juan Ignacio Enghelmayer, a pulmonologist specializing in interstitial lung diseases at the Hospital de Clínicas, noted that these delays stem from a combination of late patient presentation and misdiagnosis by primary care clinicians. Patients frequently receive prolonged courses of treatments for asthma, bronchitis, or pneumonia before undergoing specialized evaluation.

“It is not normal to lack breath at any age,” Enghelmayer stated, while emphasizing that while these pathologies occur more frequently in adults over the age of 60, dyspnea should never be treated as an inevitable consequence of aging. Clinical data indicates that this diagnostic lag directly correlates with a higher disease burden and reduced survival rates for affected individuals.

Clinical Identification and Diagnostic Pathways

During a physical examination, clinicians listen for specific auditory indicators known as velcro crackles. These abnormal pulmonary sounds resemble the tearing noise of hook-and-loop fasteners and typically occur during patient inhalation. Alongside these acoustic cues, low oxygen saturation levels measured via pulse oximetry or a bluish coloration of the fingers serve as critical warning signs requiring immediate investigation.

When physical indicators and patient histories point toward interstitial involvement, high-resolution computed tomography provides definitive imaging of structural lung damage. Specialists then synthesize these scan results alongside pulmonary function tests and detailed patient histories to determine the precise classification of the disease. Before confirming a diagnosis of idiopathic pulmonary fibrosis where the underlying trigger remains unknown, physicians must systematically rule out environmental particle inhalation, adverse pharmacological reactions, and underlying autoimmune disorders.

Autoimmune Associations and Individualized Care Pathways

A significant subset of pulmonary fibrosis cases develops secondary to systemic autoimmune conditions. Rheumatoid arthritis and systemic sclerosis are among the primary autoimmune diseases capable of triggering pulmonary parenchymal damage, sometimes manifesting before patients notice overt respiratory symptoms. Because two individuals may present with identical clinical complaints, identifying the exact underlying etiology dictates the therapeutic approach and ongoing monitoring strategy.

Medical guidelines stress that any unexplained shortness of breath during mild exertion or a dry cough lasting several months warrants prompt medical evaluation by qualified pulmonology specialists. Early identification allows healthcare providers to implement appropriate disease-management protocols, mitigate functional decline, and optimize supportive care for patients managing progressive interstitial lung disease.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Worth a look

  • ADHD UK seeks judicial review over West Yorkshire NHS waiting period
  • Google pilots program to compensate publishers for AI content usage
  • Argentina Names Cristian Cuti Romero Captain as Number 10 Stays Vacant (time.news)

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: office@world-today-news.com

Privacy Policy Terms of Service